Jpmorgan Chase & Co. - Net Worth and Insider Trading
Jpmorgan Chase & Co. Net Worth
The estimated net worth of Jpmorgan Chase & Co. is at least $124 Million dollars as of 2024-11-08. Jpmorgan Chase & Co. is the of Viva Biotech Holdings and owns about 133,261,828 shares of Viva Biotech Holdings (HKSE:01873) stock worth over $124 Million. Details can be seen in Jpmorgan Chase & Co.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jpmorgan Chase & Co. has not made any transactions after 2023-11-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Jpmorgan Chase & Co.
Jpmorgan Chase & Co. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jpmorgan Chase & Co. owns 1 companies in total, including Viva Biotech Holdings (HKSE:01873) .
Click here to see the complete history of Jpmorgan Chase & Co.’s form 4 insider trades.
Insider Ownership Summary of Jpmorgan Chase & Co.
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
HKSE:01873 | Viva Biotech Holdings | 2023-11-21 | 2201 Interest of corporation controlled by you |
Jpmorgan Chase & Co. Latest Holdings Summary
Jpmorgan Chase & Co. currently owns a total of 1 stock. Jpmorgan Chase & Co. owns 133,261,828 shares of Viva Biotech Holdings (HKSE:01873) as of November 21, 2023, with a value of $124 Million.
Latest Holdings of Jpmorgan Chase & Co.
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
HKSE:01873 | Viva Biotech Holdings | 2023-11-21 | 133,261,828 | 0.93 | 123,933,500 |
Holding Weightings of Jpmorgan Chase & Co.
Jpmorgan Chase & Co. Form 4 Trading Tracker
According to the SEC Form 4 filings, Jpmorgan Chase & Co. has made a total of 108 transactions in Viva Biotech Holdings (HKSE:01873) over the past 5 years, including 2 buys and 3 sells. The most-recent trade in Viva Biotech Holdings is the sale of 0 shares on November 21, 2023, which brought Jpmorgan Chase & Co. around $0.
Insider Trading History of Jpmorgan Chase & Co.
- 1
Jpmorgan Chase & Co. Trading Performance
GuruFocus tracks the stock performance after each of Jpmorgan Chase & Co.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jpmorgan Chase & Co. is -1.96%. GuruFocus also compares Jpmorgan Chase & Co.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Jpmorgan Chase & Co. within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Jpmorgan Chase & Co.'s insider trading performs compared to the benchmark.
Performance of Jpmorgan Chase & Co.
Jpmorgan Chase & Co. Ownership Network
Ownership Network List of Jpmorgan Chase & Co.
Ownership Network Relation of Jpmorgan Chase & Co.
Jpmorgan Chase & Co. Owned Company Details
What does Viva Biotech Holdings do?
Who are the key executives at Viva Biotech Holdings?
Jpmorgan Chase & Co. is the 2201 Interest of corporation controlled by you of Viva Biotech Holdings. Other key executives at Viva Biotech Holdings include 2101 Beneficial owner Mao Chen Cheney , 2201 Interest of corporation controlled by you Wu John Jiong , and 2101 Beneficial owner Fenghe Harvest Ltd .
Viva Biotech Holdings (HKSE:01873) Insider Trades Summary
Over the past 18 months, Jpmorgan Chase & Co. made 30 insider transaction in Viva Biotech Holdings (HKSE:01873) with a net purchase of 14,701,199. Other recent insider transactions involving Viva Biotech Holdings (HKSE:01873) include a net sale of 0 shares made by Mao Chen Cheney , a net sale of 0 shares made by Fenghe Harvest Ltd , and a net sale of 0 shares made by Temasek Holdings (Private) Limited .
In summary, during the past 3 months, insiders sold 0 shares of Viva Biotech Holdings (HKSE:01873) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Viva Biotech Holdings (HKSE:01873) were sold and 14,701,199 shares were bought by its insiders, resulting in a net purchase of 14,701,199 shares.
Viva Biotech Holdings (HKSE:01873)'s detailed insider trading history can be found in Insider Trading Tracker table.
Viva Biotech Holdings Insider Transactions
Jpmorgan Chase & Co. Mailing Address
Above is the net worth, insider trading, and ownership report for Jpmorgan Chase & Co.. Currently GuruFocus does not have mailing address information for Jpmorgan Chase & Co..